The stock of Allergan Plc (NYSE:AGN) registered an increase of 0.43% in short interest. AGN’s total short interest was 4.84 million shares in February as published by FINRA. Its up 0.43% from 4.82 million shares, reported previously. With 2.66 million shares average volume, it will take short sellers 2 days to cover their AGN’s short positions. The stock increased 3.52% or $9.71 during the last trading session, hitting $285.46. Allergan plc Ordinary Shares (NYSE:AGN) has declined 9.61% since July 17, 2015 and is downtrending. It has underperformed by 1.09% the S&P500.
The institutional sentiment decreased to 0.55 in 2015 Q3. Its down 5.45, from 6 in 2015Q2. The ratio fall, as 14 funds sold all Allergan plc Ordinary Shares shares owned while 6 reduced positions. 6 funds bought stakes while 5 increased positions. They now own 68,008 shares or 81.40% less from 365,652 shares in 2015Q2.
Peregrine Asset Advisers Inc. holds 3.11% of its portfolio in Allergan plc Ordinary Shares for 11,219 shares. Chartist Inc Ca owns 2,012 shares or 1.95% of their US portfolio. Moreover, Altavista Wealth Management Inc. has 1.78% invested in the company for 9,960 shares. The Virginia-based Old Dominion Capital Management Inc has invested 1.51% in the stock. Mitchell Mcleod Pugh & Williams Inc, a Alabama-based fund reported 4,175 shares.
Out of 15 analysts covering Allergan Inc. (NYSE:AGN), 16 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Allergan Inc. was the topic in 22 analyst reports since July 29, 2015 according to StockzIntelligence Inc. Wells Fargo initiated the stock on February 19 with “Outperform” rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
